The Metabolite Identification and Material Balance Study of SP2086

NCT02815748 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: SP2086

Sponsor

Jiangsu HengRui Medicine Co., Ltd.